“Lung Cancer Talk”: A Review of Data from the ASCO 2020 Virtual Meeting - Episode 4

KRAS-Mutant NSCLC

, , ,
EP. 1: RET Fusion+ mNSCLC
EP. 2: MET Exon 14 Mutations in mNSCLC
EP. 3: HER2 Targeted Therapy for Treatment of NSCLC
Now Viewing
EP. 4: KRAS-Mutant NSCLC
EP. 5: EGFR Exon 20 Mutations in NSCLC
EP. 6: Updates on I/O Therapy for Non-Driver mNSCLC

Advancements in drugs targeting KRAS G12C mutations and incorporating AMG 510 and MRTX849 into clinical practice when treating mNSCLC.